rs3828610
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002609.4(PDGFRB):c.-672T>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.487 in 150,962 control chromosomes in the GnomAD database, including 19,661 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 19661 hom., cov: 31)
Consequence
PDGFRB
NM_002609.4 upstream_gene
NM_002609.4 upstream_gene
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.445
Publications
15 publications found
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]
PDGFRB Gene-Disease associations (from GenCC):
- acroosteolysis-keloid-like lesions-premature aging syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- myofibromatosis, infantile, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- basal ganglia calcification, idiopathic, 4Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- bilateral striopallidodentate calcinosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile myofibromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary progressive mucinous histiocytosisInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.713 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PDGFRB | NM_002609.4 | c.-672T>G | upstream_gene_variant | ENST00000261799.9 | NP_002600.1 | |||
| PDGFRB | NM_001355016.2 | c.-818T>G | upstream_gene_variant | NP_001341945.1 | ||||
| PDGFRB | NM_001355017.2 | c.-1189T>G | upstream_gene_variant | NP_001341946.1 | ||||
| PDGFRB | NR_149150.2 | n.-217T>G | upstream_gene_variant |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PDGFRB | ENST00000261799.9 | c.-672T>G | upstream_gene_variant | 1 | NM_002609.4 | ENSP00000261799.4 | ||||
| PDGFRB | ENST00000520579.5 | n.-672T>G | upstream_gene_variant | 1 | ENSP00000430026.1 | |||||
| PDGFRB | ENST00000517660.1 | n.-202T>G | upstream_gene_variant | 3 | ||||||
| PDGFRB | ENST00000523456.1 | n.-190T>G | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.487 AC: 73479AN: 150848Hom.: 19619 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
73479
AN:
150848
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.487 AC: 73587AN: 150962Hom.: 19661 Cov.: 31 AF XY: 0.484 AC XY: 35696AN XY: 73684 show subpopulations
GnomAD4 genome
AF:
AC:
73587
AN:
150962
Hom.:
Cov.:
31
AF XY:
AC XY:
35696
AN XY:
73684
show subpopulations
African (AFR)
AF:
AC:
29715
AN:
41286
American (AMR)
AF:
AC:
6836
AN:
15178
Ashkenazi Jewish (ASJ)
AF:
AC:
1918
AN:
3468
East Asian (EAS)
AF:
AC:
2959
AN:
5110
South Asian (SAS)
AF:
AC:
1914
AN:
4758
European-Finnish (FIN)
AF:
AC:
3480
AN:
10324
Middle Eastern (MID)
AF:
AC:
172
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25270
AN:
67550
Other (OTH)
AF:
AC:
1035
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1796
3592
5389
7185
8981
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1707
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.